Respectively, they engrafted CT26 cells and B16-F10 cells with recombinant human GSDMB into mice subcutaneously, and found that GZMA/GSDMB pathway-mediated pyroptosis strengthened tumor clearance in the mouse model by enhancing the therapeutic efficacy of antitumor immunity. This evidence concerns the gene GZMA and neoplasm.